When to start antiretroviral therapy: as soon as possible

BACKGROUND: The debate regarding ‘When to Start’ antiretroviral therapy has raged since the introduction of zidovudine in 1987. Based on the entry criteria for the original Burroughs Wellcome 002 study, the field has been anchored to CD4 cell counts as the prime metric to indicate treatment initiati...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Ricardo A, Saag, Michael S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682940/
https://www.ncbi.nlm.nih.gov/pubmed/23767762
http://dx.doi.org/10.1186/1741-7015-11-147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682940/
https://www.ncbi.nlm.nih.gov/pubmed/23767762
http://dx.doi.org/10.1186/1741-7015-11-147

Ejemplares similares